Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F0YF3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,785
Award facts
- Contract value 100% obligated
- $21,784.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,784.51 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This non-set-aside competitive award is scheduled for completion by December 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used to lower cholesterol levels in patients with cardiovascular disease, representing specialized pharmaceutical support for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of brand-name and generic medications, specialty drugs, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills federal requirements through competitively awarded contracts demonstrating its capability to manage diverse medical supply needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F0YF3?
SPE2DR26F0YF3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F0YF3 worth?
The government has obligated $21,785 on SPE2DR26F0YF3.
Is contract SPE2DR26F0YF3 an order under another contract?
Yes. SPE2DR26F0YF3 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0YF3 competed?
The extent of competition for SPE2DR26F0YF3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award